Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates - Nasdaq
7 hours ago • Google News
Lexicon Pharmaceuticals Inc (LXRX)
US$ 1.27-2.31%
Price Chart
Key Statistics
Market Cap
$ 244.75M
P/E Ratio
0.00
Revenue (TTM)
$ 31.08M
Volume
2.94M
52W High
$ 2.45
52W Low
$ 0.28
Dividend Yield
0.00%
Beta
1.08
Technicals
50-Day MA
0.5018
200-Day MA
1.0958
52 Week High
2.45
52 Week Low
0.2836
About LXRX
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
Employees
103
Headquarters
The Woodlands, TX
CEO
Dr. Michael S. Exton Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg